Genic

123330 · KOSDAQ · ₩123330 · 제닉

₩15,470▼ ₩400 (2.52%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩49B₩29B₩12B₩24B₩25B₩18B₩19B₩15B
Cost of sales₩37B₩24B₩9.9B₩16B₩17B₩13B₩14B₩11B
Gross profit₩12B₩5.6B₩2.3B₩7.6B₩7.4B₩5.3B₩5.1B₩3.8B
Operating income₩10B₩3.4B₩104M₩5.6B₩5.5B₩3.8B₩3.6B₩2.1B
Net income₩7.7B₩3.5B₩14B₩1.3B₩484M₩3.5B₩5.7B₩1.1B
Net income to shareholders₩11B₩3.5B₩14B₩1.3B₩484M₩3.5B₩5.7B₩1.1B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩91B₩67B₩57B₩50B₩50B₩42B₩38B₩32B
Current assets₩60B₩39B₩31B₩33B₩34B₩24B₩21B₩19B
Cash and equivalents₩3.7B₩5.3B₩13B₩12B₩7.6B₩5.6B₩1.3B₩403M
Total liabilities₩35B₩22B₩15B₩15B₩20B₩16B₩16B₩16B
Current liabilities₩33B₩20B₩13B₩14B₩20B₩15B₩15B₩16B
Borrowings₩3B₩1.5B₩2.2B₩5B₩5B₩5B₩5B₩5B
Total equity₩56B₩45B₩41B₩35B₩30B₩26B₩22B₩17B
Shareholders' equity₩56B₩45B₩41B₩35B₩30B₩26B₩22B₩17B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩1.4B−₩5.5B₩7.7B₩5.6B₩2.8B₩4.6B₩1.8B−₩364M
Capital spending₩3B₩2.3B₩945M₩1B₩620M₩99M₩896M₩649M
Free cash flow−₩4.5B−₩7.8B₩6.8B₩4.6B₩2.1B₩4.5B₩892M−₩1B

Consolidated where available. Amounts in won.

Also known as: Genic / 제닉 / 123330 / KRX:123330

Source: KRX statistical information